UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| Date of Report (Date of Earliest Event Reported): | May 8, 2012 |
Charles River Laboratories International, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
| Delaware | 001-15943 | 06-1397316 |
|
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| 251 Ballardvale St., Wilmington, Massachusetts | 01887 | |
|
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
| Registrant’s telephone number, including area code: | 781-222-6000 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07 Submission of Matters to a Vote of Security Holders
Charles River Laboratories International, Inc. (the “Company”) held its Annual Meeting of Shareholders on May 8, 2012. For more information on the following proposals, see the Company’s proxy statement dated March 30, 2012. At the Annual Meeting the proposals were adopted by the votes specified below:
| (a) | The following ten (10) directors were elected to serve until the Company’s 2013 Annual Meeting of Shareholders and received the number of votes listed opposite each of their names below: |
| Number of | Number of | |||||||||||
| Shares Voted For | Shares Withheld | Broker Non-Votes | ||||||||||
James C. Foster |
41,412,893 | 931,554 | 2,636,858 | |||||||||
Robert J. Bertolini. |
42,193,351 | 151,096 | 2,636,858 | |||||||||
Stephen D. Chubb |
38,565,658 | 3,778,789 | 2,636,858 | |||||||||
Deborah T. Kochevar. |
32,856,098 | 9,488,349 | 2,636,858 | |||||||||
George E. Massaro |
41,173,968 | 1,170,479 | 2,636,858 | |||||||||
George M. Milne, Jr. |
42,191,911 | 152,536 | 2,636,858 | |||||||||
C. Richard Reese |
33,194,572 | 9,149,875 | 2,636,858 | |||||||||
Samuel O. Thier |
39,565,602 | 2,778,845 | 2,636,858 | |||||||||
Richard F. Wallman |
37,367,180 | 4,977,267 | 2,636,858 | |||||||||
William H. Waltrip |
29,157,749 | 13,186,698 | 2,636,858 | |||||||||
| (b) | The shareholders did not approve, on an advisory, non-binding basis, the compensation of our named executive officers. |
| For | Against | Abstain | Broker Non-Votes | |||||||||
15,274,503
|
27,050,696 | 19,248 | 2,636,858 | |||||||||
While this vote is advisory, the Board of Directors takes these results seriously and intends to factor its shareholders’ views into its executive compensation program.
| (e) | The shareholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditors for fiscal 2012. |
| For | Against | Abstain | Broker Non-Votes | |||||||||
44,505,064
|
457,835 | 18,406 | 0 | |||||||||
| (e) | The shareholders did not approve the Shareholder Proposal submitted by PETA to require annual reports by the Board of Directors pertaining to USDA citations and animal welfare considerations. |
| For | Against | Abstain | Broker Non-Votes | |||||||||
1,583,940
|
33,445,457 | 7,315,050 | 2,636,858 | |||||||||
Computershare Trust Company, N.A., our transfer agent, acted as independent proxy tabulator and Inspector of Election at the Annual Meeting of Shareholders.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Charles River Laboratories International, Inc. | ||||
| May 11, 2012 | By: |
/s/ Matthew L. Daniel
|
||
|
|
||||
| Name: Matthew L. Daniel | ||||
| Title: Corporate Vice President, Deputy General Counsel and Assistant Secretary | ||||